Berkeley, California, USA
Using our novel platform technology, we at Nanotein, help overcome the CAR-T industry challenges by: (1) accelerating CAR-T expansion, (2) enhancing expansion to grow more cells per treatment, and (3) shifting the growth profile of CAR-T cultures to favor the expansion of the most long-lived and clinically effective CAR-T cell sub-populations. The uniquely tunable and flexible nature of our platform technology also allows us to easily modify our product. With the ability to make these simple changes we can grow CAR-T and T-cell cultures with new cell population profiles and growth curves.
No key contacts have been added to this profile yet.
This is the company profile page for Nanotein Technologies on the Pharma Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.